Member Info for Dosanddonts

3.8mill sales for uk 6month eu 3month saudi 6month versus full year uk & belgium revenue of 3.1mill, & £2mill in first 3month. so £2.3mill from eu & saudi???? this also includes launch stock? i’ve seen zero advertising in uk for the last 6month?? maybe we will get a surge of advertising when us launch officially in oct! barder needs to employ a spokes person he is ****!!!!!

In most countries it has been a best seller & out sold forecasted sales, not sure what FUM targets were as market sensitive bull! but I don’t think they expected 20% market share from the outset! Sales surely have to be positive if not then the Broker JB needs shooting (Needs shooting regardless UMO 😆). He did also state in very recent communication they were on target for forecasted sales so can’t be bad & with US early launch yearly forecast should have improved.

I’m hoping the news next week will be positive regardless of what the Broker says, surely he can’t f up Revenue & profit figures for the past 6month. With the early £4mill for US launch that’s been forecast & 3month sales in US for end of year, SP will move rapidly over the next 3month. What was surprising was that when the US returned Tuesday the SP dropped so zero interest in FUM shares in the US, well done FUM f’in idiots zero exposure to US share market IMO otherwise we would have seen some movement! They are really bigging the company Up NOT!

James Barder was originally an insurance broker! Says it all really Zero charisma, zero risk tolerance! Nothing against anybody who is an insurance broker but not someone I would want managing a company selling Erections! Only death & disaster which he brings to FUM!

Just found on Amazon US but thought it was a copycat product, why have they changed the packaging?

https://www.amazon.com/Eroxon-Erectile-Dysfunction-Treatment-Clinically/dp/B0DBWQH8N1/ref=mp_s_a_1_1?dib=eyJ2IjoiMSJ9.qyLI196IUz1sCRrQRbzltVtcmarO91DeM1HIcnzd14SU7QU1JKIsEj7jbXStNEa6d4RZNoOkJ8ECpdSRRaEm-9YWMFGjFqST3DGvuJELws54ZsZ8uVwd5hvFr5AMQsqTzYto4Sm6gt2V88IngeLj6micGC32ZVpg4WxHcS6ixc67epQ9DgM_sAppg7P3FbO6CFy28hmgXXES4vkEOUvOBw.ShHHX6CXDn9CeIW-2oNk7tDu8CP_wUG7m9tmrZz7iU4&dib_tag=se&keywords=eroxon+ed&qid=1725266686&sr=8-1

We now know launch is October & pre-orders has started 1st Sep. So would expect a revised revenue update soon or during mid years on the 10th! The BOD need to do some real number crunching, not this bull that they can’t disclose or make real number predictions!

Do we think the pre-order numbers will be made public? Let’s hope there strong if so! as looks like the only thing that is going to move this SP is revenue figures! Was expecting a larger move on this news at least back to our highs of 65! But No & as stated what a poor RNS.

What is going on with the China deal?? Got out of the original deal as they weren’t moving fast enough now over a year & no deal?? Can we sack the BOD as they aren’t moving fast enough? I wish! Let’s hope the 10th is enlightening.

Maybe because they have scrapped all R&D into new products, TPR100 was in the final stages ready to go & now it’s been scrapped! Same as many other products WHY? FUM was an R&D company your right but why remove all trace of theses products from their website?? All history of their R&D strengths? IMO makes a sale of the company easier as only need to value one product Eroxon! Why else would you do that? Love to know? As to me all those R&D products made FUM more attractive as an investor.

Let’s hope the BOD have some hidden gems on the mid years 10th Sep! Find it hard to understand how 2024 is a break even year or maybe a slight loss? Haleon responsible for manufacturing & distribution but Coopers are just the distributor so guessing maybe the setup of additional manufacturing site! But based on numbers they are talking revenue of £10mill so about £6mil profit, which would mean £6mil expenditure with salaries at around £1.5mil that 4.5mil on something???

I can’t wait for the buy out & the dumping of Barder & the rest of the BOD! Aggressive takeover im hoping for but I’m a bitter LTH! Confidence in the product but zero in the BOD! More luck than good research but the idiot BOD think they are good at research?? Makes me laugh & cry at times!

Haleon ain’t going to release a product next to Xmas as would be a waste of money advertising at that time & costly IMO! I’m hoping mid Nov early to mid!if not before.

The SP makes no sense here 6month from US launch with EU launches that are best sellers? I see a buy out coming very soon IMO! The BOD are useless they have should have good financials & refuse to give guidance? Why? This is a new products & news should be flowing but the BOD refuse! Why? We should see admin costs massively reduce but I feel the BOD have failed to limit costs & the financials will not be so great due to mis-management! Get shot of them!

How the hell is this still creeping downwards??

Gary- for what to enter the blood stream?? This is a medical device that causes heating & cooling to cause an erection! There is no drug to enter the blood stream! DYR

Comek- just think the RNS was pointless unless something else is happening soon! I can only go off the news they release with ref to next year & guaranteed financial statement in Sep! They have released No RNS’s last 6month then this when they are not obliged to! Why! Seems like a nonsense RNS.

This is good news but I question why an RNS? When they have refused to release any data for the last 6month?

What was that RNS for? They could have updated market with financials but NO! Pointless RNS unless Haleon are due to launch very soon!

The news that’s coming is the mid year financials but not until Sep, must be good considering they have now released into 10 more countries & have had to supply stock for all launches! I’m not expecting US launch news until new year

Haleon much larger company with many products FUM tiny with one product (Risky still). Units sold is not sensitive data so why are they hiding this? 20% share of ED market is not good enough! Confidence in the fact big players are still in fully! So hold on for the eventual takeoff.

As we know this share has been manipulated for years now! to get short term gains +-20% at times. BOD see no interest in trying to address the SP short term players & to some degree I agree! Once the US launch is confirmed then the financials will have an effect but even at 20million revenue currently it is not going to have a major effect on the SP. So I’m hoping mid year financials coincide with US launch!